CompletedNCT04113551
A Study of Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan
Observational studyUnited States
Understand this study
- Listed locations
- TitusvilleSee all locations and recruitment
Study information
Study start dateStarted: October 1, 2019
- Recruitment status
- Completed
- Enrollment listed in the registry
- 17,418
- Sponsor
- Janssen Research & Development, LLC
- Sponsor type
- Other organization
- Study type
- Observational
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- Not clearly listed
- Official registry ID
- NCT04113551
- Official title
Show the full official title
Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan: A Retrospective Cohort Study of Label Compliance
Recruitment & locations
CompletedTitusville
Questions about this study
Who is behind this study?
The study sponsor is Janssen Research & Development, LLC.
Did this study involve medication?
Yes. The study involved medication, including MPH (Concerta), MPH (Ritalin), Atomoxetine (ATO) and Guanfacine (GFC).
Want to find a study that may fit you better?
Explore HopeStage studies by mental health topic and refine the results to suit your situation.
Find a study that may fit meRelated studies
A comparison of lifestyle patterns in children with/without Attention Deficit Hyperactivity Disorder
A Naturalistic Study of Functional Impairment for Individuals With ADHD in the Early Morning and Late Afternoon/Evening Hours